Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-06Clinical Trial Update: Middle Meningeal Artery Embolization for Chronic Migraine [NA]
The clinical trial NCT07044648 evaluating middle meningeal artery embolization for chronic migraine has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-02-04Clinical Trial Update: Clinical Applications of High-Frequency Oscillations
A clinical trial investigating the clinical applications of high-frequency oscillations for epilepsy and migraine has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-01-13Clinical Trial Update: A Study to Learn About Zavegepant as a Treatment for Multiple Migraine Attacks in Adult Participants [Phase 3]
Pfizer has withdrawn a Phase 3 trial evaluating Zavegepant for treating multiple migraine attacks in adults. The study was intended to asses…
-
CLINICAL_TRIALS withdrawal · 2025-12-08Clinical Trial Update: Single-Site Study of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Phase 2 Randomized Trial [Phase 2]
The document notes that the Phase 2 randomized trial of naltrexone/acetaminophen for acute migraine treatment has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-07-29Clinical Trial Update: Haldol/Diphenhydramine Versus Metoclopramide/Diphenhydramine for Treatment of Acute Headache in the ED: A RCT [Phase 4]
A Phase 4 randomized trial comparing haloperidol with diphenhydramine versus metoclopramide with diphenhydramine for acute headaches (migrai…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-07-02Clinical Trial Update: Healthy Living Partnerships for Veterans With Migraine [NA]
The Wake Forest University Health Sciences-sponsored clinical trial 'Healthy Living Partnerships for Veterans With Migraine' has been withdr…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Migraine Headaches
The non-interventional pilot trial investigating the role of gut flora in migraine headaches has been withdrawn. No results were reported an…
-
CLINICAL_TRIALS withdrawal · 2025-05-08Clinical Trial Update: Study of Wireless Nerve Stimulation in the Treatment of Chronic Migraine [Phase 3]
A Phase 3 trial evaluating wireless nerve stimulation for chronic migraine has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-04-16Clinical Trial Update: Analysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma [NA]
A clinical trial (NCT04196933) evaluating vestibular compensation after intervention for vestibular schwannoma has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-12-02Clinical Trial Update: Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for Preventive Treatment of Migraine [NA]
A clinical trial evaluating combined occipital and trigeminal nerve stimulation (eCOT-NS) for preventive treatment of migraine has been with…
-
CLINICAL_TRIALS withdrawal · 2024-09-19Clinical Trial Update: Onabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular Headache [Phase 1]
A Phase 1 trial evaluating Onabotulinumtoxin A (Botox) for persistent post-stroke and vascular headache was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-07-01Clinical Trial Update: 4-Aminopyridine, Atenolol, or Placebo in Patients With Vestibular Migraine [Phase 2]
Phase 2 clinical trial evaluating 4-aminopyridine, atenolol, or placebo in vestibular migraine has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-11-26Clinical Trial Update: A Research Study of Greater Occipital Nerve Block as a Treatment for Acute Migraine Attacks [Phase 4]
A Phase 4 clinical trial investigating greater occipital nerve block for acute migraine attacks has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-06-01Clinical Trial Update: Study of Quality of Life in Subjects With Chronic or High-frequency Episodic Migraine and Associated Comorbidities Treated With Erenumab [Phase 3]
A Phase 3 study evaluating quality of life in chronic or high-frequency episodic migraine patients treated with erenumab has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-11-29Clinical Trial Update: Improving Health Outcomes of Migraine Patients Who Present to the Emergency Department [Phase 4]
A Phase 4 clinical trial on improving migraine outcomes in patients presenting to the Emergency Department has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-04-10Clinical Trial Update: Cefaliv® Compared to Neosaldina® in the Treatment of Migraine Attacks [Phase 3]
Phase 3 trial Cefaliv® vs Neosaldina® for migraine attacks was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-08Clinical Trial Update: Facilitating Migraine Medication Adherence and Optimizing Medication Use
This clinical trial update notes that the study aimed at improving adherence to migraine medications and optimizing their use has been withd…
-
CLINICAL_TRIALS withdrawal · 2017-08-24Clinical Trial Update: Trial on Metoclopramide and Ketoprofen in Acute Migraine of Childhood [Phase 3]
A Phase 3 trial evaluating metoclopramide in combination with ketoprofen for acute migraine in children was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-14Clinical Trial Update: Open Label Study of BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Patients With Chronic Migraine [Phase 3]
An open-label Phase 3 trial evaluating BOTOX (botulinum toxin type A) for chronic migraine in Chinese patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-07-14Clinical Trial Update: BOTOX® (Botulinum Toxin Type A) as Headache Prophylaxis in Chinese Participants With Chronic Migraine [Phase 3]
A Phase 3 trial evaluating BOTOX (onabotulinumtoxinA) for headache prevention in Chinese participants with chronic migraine has been withdra…
-
CLINICAL_TRIALS withdrawal · 2017-04-20Clinical Trial Update: A Randomized,Double Blind, Placebo Controlled Study to Assess Efficacy,Safety and Tolerability of BGG492 in Migraine Prevention [Phase 2]
This Phase 2 randomized, double-blind, placebo-controlled trial of BGG492 for migraine prevention has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-03Clinical Trial Update: Intranasal Cooling for Symptomatic Relief of Migraine [NA]
A clinical trial evaluating intranasal cooling for migraine relief conducted by Cumbria Partnership NHS Foundation Trust has been terminated…
-
CLINICAL_TRIALS withdrawal · 2016-12-29Clinical Trial Update: The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine [NA]
Clinical trial investigating the impact of triptan and doxycycline on neuroinflammatory biomarkers in acute migraine has been withdrawn. Spo…
-
CLINICAL_TRIALS withdrawal · 2016-10-19Clinical Trial Update: Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine [Phase 3]
A Phase 3 clinical trial evaluating a fixed-dose combination of naratriptan and naproxen for acute treatment of migraine has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-03-16Clinical Trial Update: Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine. [Phase 3]
Phase 3 trial evaluating a fixed-dose Naratriptan/Naproxen combination for acute treatment of migraine was withdrawn.